Ionis Pharmaceuticals Inc (IONS)
42.45
+0.61
(+1.46%)
USD |
NASDAQ |
Apr 24, 16:00
42.46
+0.01
(+0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Operations (TTM): -307.51M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -307.51M |
| September 30, 2023 | -540.57M |
| June 30, 2023 | -455.98M |
| March 31, 2023 | -376.71M |
| December 31, 2022 | -274.37M |
| September 30, 2022 | 129.51M |
| June 30, 2022 | 98.37M |
| March 31, 2022 | 53.81M |
| December 31, 2021 | 30.80M |
| September 30, 2021 | -74.91M |
| June 30, 2021 | -29.61M |
| March 31, 2021 | -11.18M |
| December 31, 2020 | 35.89M |
| September 30, 2020 | 215.75M |
| June 30, 2020 | 213.22M |
| March 31, 2020 | 230.33M |
| December 31, 2019 | 345.63M |
| September 30, 2019 | 183.30M |
| June 30, 2019 | 170.10M |
| March 31, 2019 | 697.45M |
| December 31, 2018 | 602.91M |
| September 30, 2018 | 507.80M |
| June 30, 2018 | 562.52M |
| March 31, 2018 | 64.65M |
| December 31, 2017 | 174.15M |
| Date | Value |
|---|---|
| September 30, 2017 | 126.91M |
| June 30, 2017 | 122.48M |
| March 31, 2017 | 86.33M |
| December 31, 2016 | -112.10M |
| September 30, 2016 | -122.74M |
| June 30, 2016 | -110.81M |
| March 31, 2016 | -11.82M |
| December 31, 2015 | 21.12M |
| September 30, 2015 | 129.28M |
| June 30, 2015 | 95.01M |
| March 31, 2015 | -4.213M |
| December 31, 2014 | 6.285M |
| September 30, 2014 | -78.89M |
| June 30, 2014 | -15.01M |
| March 31, 2014 | 41.74M |
| December 31, 2013 | 63.49M |
| September 30, 2013 | 114.02M |
| June 30, 2013 | 23.33M |
| March 31, 2013 | -1.989M |
| December 31, 2012 | 1.876M |
| September 30, 2012 | -56.90M |
| June 30, 2012 | -55.20M |
| March 31, 2012 | -78.80M |
| December 31, 2011 | -111.93M |
| September 30, 2011 | -114.69M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-540.57M
Minimum
Sep 2023
345.63M
Maximum
Dec 2019
-19.17M
Average
35.89M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -324.23M |
| Viking Therapeutics Inc | -73.38M |
| Alnylam Pharmaceuticals Inc | 104.16M |
| Akero Therapeutics Inc | -145.37M |
| 89bio Inc | -129.19M |